Merck gets FDA approval for Ervebo vaccine for prevention of Ebola
Ervebo is now the first FDA-approved vaccine for Ebola and is indicated to be used in people aged…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 Dec 19
Ervebo is now the first FDA-approved vaccine for Ebola and is indicated to be used in people aged…
19 Dec 19
BLISS-LN clinical trial evaluated the safety and efficacy of Benlysta in the enrolled 448 patients with active lupus…
19 Dec 19
TRIUMPH clinical trial is expected to enrol approximately 2,850 patients from multiple sites across the US, Europe and…
18 Dec 19
Lynparza is a PARP inhibitor that blocks DNA damage response (DDR) in tumour cells and leads to the…
18 Dec 19
CytoDyn intends to obtain FDA approval for leronlimab in combination therapy, and file a biologics license application (BLA)…
17 Dec 19
XTANDI is an androgen receptor inhibitor intended for treating castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer
16 Dec 19
If approved, the new formulation of DTG is expected to be the first integrase inhibitor offered as a…
13 Dec 19
Pfizer has subjected its XELJANZ to more than 50 clinical trials across the world, of which more than…
Zip Health will offer the same range of prescription drugs online as its UK equivalent - once the…
12 Dec 19
LOXO-292 is a highly selective and potent, oral investigational medicine, which is currently under clinical development for the…